Document is current
Any future updates will be listed below
-
Authors
Scott, N. P.
Teoh, E. J.
Flight, H.
Jones, B. E.
Niederer, J.
Mustata, L.
MacLean, G. M.
Roy, P. G.
Remoundos, D. D.
Snell, C. http://orcid.org/0000-0001-7847-3041
Liu, C.
Gleeson, F. V.
Harris, A. L. http://orcid.org/0000-0003-1376-8409
Lord, S. R. http://orcid.org/0000-0001-7946-5609
McGowan, D. R. http://orcid.org/0000-0002-6880-5687
-
Funding
Funding for this research was provided by:
Cancer Research UK (C5255/A23755, C5255/A16466, C34326/A28684, C42780/A27066)
DH | NIHR | Research Trainees Coordinating Centre (ICA-CL-2016-02-009)
- License Information
-
More Information
Article History
Received: 4 June 2021
Revised: 25 October 2021
Accepted: 29 October 2021
First Online: 18 November 2021
Ethics approval and consent to participate
: The study was prospectively approved by the Oxford A Research Ethics Committee and registered with ClinicalTrials.gov identifier: NCT03036943. All patients involved gave written informed consent. The study was performed in accordance with the Declaration of Helsinki.
: No individual person’s data is contained within this manuscript.
: At the time of submission, EJT is an employee of Blue Earth Diagnostics. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, HEE or the Department of Health and Social Care. The authors declare no competing interests.
